Discontinuation report EGRIFTA

Last updated on 2022-09-22 History
Report ID 170025
Drug Identification Number 02438712
Brand name EGRIFTA
Common or Proper name Tesamorelin for injection
Company Name THERATECHNOLOGIES INC
Market Status MARKETED
Active Ingredient(s) TESAMORELIN
Strength(s) 1MG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 60 vials containing (each) 1 mg of tesamorelin
ATC code H01AC
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-09-30
Actual discontinuation date
Remaining supply date 2022-09-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2015 PEEL STREET
MONTREAL, QUEBEC
CANADA H3A 1T8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-09-22 French Compare
v1 2022-09-22 English Compare

Showing 1 to 2 of 2